Key Details
Price
$31.99PE Ratio
24.19Annual ROE
7.55%Beta
0.54Events Calendar
Next earnings date:
May 8, 2025Recent quarterly earnings:
Feb 25, 2025Recent annual earnings:
Feb 25, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 26, 25 Cantor Fitzgerald
NeutralFeb 19, 25 Cantor Fitzgerald
NeutralSep 11, 24 Piper Sandler
NeutralFeb 28, 24 Piper Sandler
OverweightNov 9, 23 Piper Sandler
OverweightOct 25, 23 Piper Sandler
OverweightMay 10, 23 Piper Sandler
OverweightJan 23, 23 Piper Sandler
OverweightAug 31, 22 Piper Sandler
OverweightApr 13, 21 Jefferies
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Supernus Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Supernus Pharmaceuticals?
- Does Supernus Pharmaceuticals pay dividends?
- What sector is Supernus Pharmaceuticals in?
- What industry is Supernus Pharmaceuticals in?
- What country is Supernus Pharmaceuticals based in?
- When did Supernus Pharmaceuticals go public?
- Is Supernus Pharmaceuticals in the S&P 500?
- Is Supernus Pharmaceuticals in the NASDAQ 100?
- Is Supernus Pharmaceuticals in the Dow Jones?
- When was Supernus Pharmaceuticals's last earnings report?
- When does Supernus Pharmaceuticals report earnings?
- Should I buy Supernus Pharmaceuticals stock now?
What is the ticker symbol for Supernus Pharmaceuticals?
The ticker symbol for Supernus Pharmaceuticals is NASDAQ:SUPN
Does Supernus Pharmaceuticals pay dividends?
No, Supernus Pharmaceuticals does not pay dividends
What sector is Supernus Pharmaceuticals in?
Supernus Pharmaceuticals is in the Healthcare sector
What industry is Supernus Pharmaceuticals in?
Supernus Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is Supernus Pharmaceuticals based in?
Supernus Pharmaceuticals is headquartered in United States
When did Supernus Pharmaceuticals go public?
Supernus Pharmaceuticals's initial public offering (IPO) was on May 1, 2012
Is Supernus Pharmaceuticals in the S&P 500?
No, Supernus Pharmaceuticals is not included in the S&P 500 index
Is Supernus Pharmaceuticals in the NASDAQ 100?
No, Supernus Pharmaceuticals is not included in the NASDAQ 100 index
Is Supernus Pharmaceuticals in the Dow Jones?
No, Supernus Pharmaceuticals is not included in the Dow Jones index
When was Supernus Pharmaceuticals's last earnings report?
Supernus Pharmaceuticals's most recent earnings report was on Feb 25, 2025
When does Supernus Pharmaceuticals report earnings?
The next expected earnings date for Supernus Pharmaceuticals is May 8, 2025
Should I buy Supernus Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions